Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1969 3
1970 2
1971 1
1972 3
1973 1
1974 1
1975 1
1976 2
1977 1
1978 2
1979 5
1980 2
1981 2
1982 2
1983 7
1984 3
1985 3
1986 6
1987 5
1988 9
1989 13
1990 10
1991 10
1992 6
1993 10
1994 8
1995 9
1996 9
1997 14
1998 5
1999 18
2000 30
2001 57
2002 32
2003 40
2004 53
2005 56
2006 98
2007 116
2008 134
2009 162
2010 195
2011 227
2012 262
2013 300
2014 272
2015 302
2016 318
2017 361
2018 395
2019 437
2020 613
2021 696
2022 746
2023 710
2024 805
2025 934
2026 490

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,932 results

Results by year

Filters applied: . Clear all
Page 1
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.
Chiesa R, Georgiadis C, Rashed H, Preece R, Hardefeldt P, Chu J, Selvage J, Mishra A, Ahmed B, Adams S, Thomas R, Gilmour K, Etuk A, Yallop D, O'Connor D, Qasim W; Base-Edited CAR T Group. Chiesa R, et al. Among authors: mishra a. N Engl J Med. 2026 Jan 8;394(2):152-165. doi: 10.1056/NEJMoa2505478. Epub 2025 Dec 8. N Engl J Med. 2026. PMID: 41363805 Clinical Trial.
Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.
Mishra A, Meador CB, Kikkeri K, Cunneely Q, Lin M, Carmona-LaSalle TJ, Huang SB, Bell R, Putaturo V, Xia W, Liang JH, Fang J, San Vicente S, Zielinski CE, Digumarthy SR, Hung YP, Yeap BY, Edd JF, Lawrence MS, Sade-Feldman M, Sen DR, Toner M, Maheswaran S, Gainor JF, Haber DA. Mishra A, et al. Cancer Discov. 2026 May 1;16(5):911-930. doi: 10.1158/2159-8290.CD-25-1483. Cancer Discov. 2026. PMID: 41532856 Free PMC article.
HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvement.
Farashi S, Abbott CJ, Ansell BRE, Wu Z, Altay L, Arnon E, Arnould L, Bagdasarova Y, Balaskas K, Chen FK, Chew E, Chowers I, Clarke S, Cukras C, Delcourt C, Delyfer MN, den Hollander AI, Fauser S, Finger RP, Gabrielle PH, Han J, Hodgson LAB, Hogg R, Holz FG, Hoyng C, Kumar H, Lad EM, Lee A, Luhmann UFO, Mauschitz MM, McKnight AJ, McLenachan S, Mishra A, Moghul I, Orozco LD, Sampson DM, Scott LW, Sitnilska V, Song S, Stockwell A, Swaroop A, Terheyden JH, Tiosano L, Tufail A, Yaspan BL; MACUSTAR consortium; NICOLA consortium; Pébay A, Fletcher EL, Guymer RH, Bahlo M; Reticular Pseudodrusen Consortium. Farashi S, et al. Among authors: mishra a. Nat Commun. 2025 Dec 8;16(1):10854. doi: 10.1038/s41467-025-65903-9. Nat Commun. 2025. PMID: 41361163 Free PMC article.
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial-Pembrolizumab Low dose in Addition to NACT in TNBC).
Arora A, Bhaskarane H, Tansir G, Bakhshi S, Gogia A, Kumar A, Jain R, Kalra K, Vishvam D, Mathur S, Rathore R, Shamim SA, Dhamija E, Rangarajan K, Tanwar P, Prasad CP, Kumar S, Gupta I, Mani K, Upadhyay AD, Divakar MK, Vasudeva P, Verma N, Agstam S, Vuthaluru S, Parshad R, Bansal VK, Dhar A, Krishna A, Ranjan P, Suhani S, Prakash O, Kataria K, Kumar B, Mishra A, Sharma J, Bansal B, Saikia J, Bhasker S, Haresh KP, Gupta S, Saini SK, Mallick S, Batra A. Arora A, et al. Among authors: mishra a. Ann Oncol. 2026 May;37(5):639-649. doi: 10.1016/j.annonc.2025.12.015. Epub 2025 Dec 22. Ann Oncol. 2026. PMID: 41443410 Clinical Trial.
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease.
Caro I, Western D, Namba S, Sun N, Kawaguchi S, He Y, Fujita M, Roshchupkin G, D'Aoust T, Duperron MG, Sargurupremraj M, Tsuchida A, Koido M, Ahmadi M, Yang C, Timsina J, Ibanez L, Matsuda K, Suzuki Y, Oda Y, Kanai A, Jandaghi P, Munter M, Auld D, Astafeva I, Puerta R, Rotter JI, Psaty BM, Bis JC, Longstreth WT Jr, Couffinhal T, García-González P, Pytel V, Marquié M, Cano A, Boada M, Joliot M, Lathrop M, Le Grand Q, Launer LJ, Wardlaw JM, Heiman M, Ruiz A, Matthews PM, Seshadri S, Fornage M, Adams H, Mishra A, Trégouët DA, Okada Y, Kellis M, De Jager PL, Tzourio C, Kamatani Y, Matsuda F, Cruchaga C, Debette S. Caro I, et al. Among authors: mishra a. Nat Aging. 2025 Dec;5(12):2514-2531. doi: 10.1038/s43587-025-01006-w. Epub 2025 Nov 20. Nat Aging. 2025. PMID: 41266628 Free PMC article.
Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: A randomized controlled trial.
Swaroop S, Biswas S, Aggarwal A, Coshic P, Kumar S, Agarwal S, Pandey HC, Patidar G, Chaurasia R, Arora U, Agarwal A, Acharya P, Nayak B, Gunjan D, Sardana V, Mishra AK, Gamanagatti S, Shalimar. Swaroop S, et al. Among authors: mishra ak. Hepatology. 2026 Mar 30. doi: 10.1097/HEP.0000000000001755. Online ahead of print. Hepatology. 2026. PMID: 41911559
Charting spatial ligand-target activity using Renoir.
Rao N, Kumar T, Kazemi D, Hou S, Khakpoor A, Eapen MM, Pai R, Qiao L, Mishra A, Ginhoux F, Chan JKY, George J, Sharma A, Zafar H. Rao N, et al. Among authors: mishra a. Nat Commun. 2026 May 5;17(1):3983. doi: 10.1038/s41467-026-72388-7. Nat Commun. 2026. PMID: 42086556 Free PMC article.
7,932 results